The aim of our present study was to evaluate alterations in the expression of the co-stimulatory molecules CD28, CTLA-4 and ICOS in CD4 + and CD8 + T cells of AD, VD and FTD patients. This evidence concerns the gene CD8A and Alzheimer disease.